Victim Impact Modules for Jail Inmates

April 21, 2017 updated by: June Tangney, George Mason University

Phase 1-2 Study of Victim Impact Group Modules for Jail Inmates

The purpose of this study is to evaluate feasibility of modularized delivery of the Impact of Crime (IOC) group intervention with jail inmates, and obtain preliminary data on its effectiveness in reducing post-release recidivism, substance abuse, and HIV risk behavior.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Virginia
      • Fairfax, Virginia, United States, 22030
        • Fairfax County Adult Detention Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Must be 18 years or older
  • Must be male
  • Must be currently incarcerated jail inmate
  • Must be sentenced
  • Sentence must be short enough to serve out sentence at ADC
  • Release date must follow projected final session of treatment
  • Must speak, read, and write in English with sufficient proficiency to use workbook and participate in group sessions
  • Must be assigned to the jail's "general population"

Exclusion Criteria:

  • Actively psychotic
  • Assigned "keep separate" from other group members

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Impact of Crime Modules
5 session/1 week modules of a restorative justice inspired victim impact group intervention
Behavioral: Impact of Crime Modules
5 session/1 week modules of a restorative justice inspired victim impact group intervention
Other: TAU
treatment as usual -- participants have access to all other jail programs and services
Behavioral: TAU
have access to other jail programs and services

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Recidivism - Self report of arrests and undetected crimes
Time Frame: 3 months post-release up to 9 mos
3 months post-release up to 9 mos
Acceptability - number of participants who indicate the module was helpful and number who would recommend treatment to a friend
Time Frame: 1 week post-treatment up to 2 weeks
1 week post-treatment up to 2 weeks
Number of inmates who complete the intervention
Time Frame: 5 sessions over a period of 1 week
5 sessions over a period of 1 week

Secondary Outcome Measures

Outcome Measure
Time Frame
Self reported Substance use and dependence -Texas Christian University measure
Time Frame: 3 months post-release up to 9 mos
3 months post-release up to 9 mos
Self reported HIV risk behavior (sex and Intravenous Drug Use) Texas Christian University measure
Time Frame: 3 months post-release up to 9 mos
3 months post-release up to 9 mos
Changes in self-reported Shame-proneness from baseline
Time Frame: Changes from pre- to post-treatment up to 12 weeks
Changes from pre- to post-treatment up to 12 weeks
Changes in self-reported Shame-proneness from baseline
Time Frame: Changes from pre-treatment to 3 mos post-release up to 9 mos
Changes from pre-treatment to 3 mos post-release up to 9 mos
Changes in self-reported Guilt-proneness from baseline
Time Frame: Changes from pretreatment to 3 months post-release up to 9 mos
Changes from pretreatment to 3 months post-release up to 9 mos
Changes in self-reported Guilt-proneness from baseline
Time Frame: Changes from pretreatment to post-treatment up to 12 weeks
Changes from pretreatment to post-treatment up to 12 weeks
Changes in self-reported empathy from baseline
Time Frame: changes from pre- to post-treatment up to 12 weeks
changes from pre- to post-treatment up to 12 weeks
Changes in self-reported empathy from baseline
Time Frame: changes from pre-treatment to 3 mos post-release up to 9 mos
changes from pre-treatment to 3 mos post-release up to 9 mos
Changes in self reported criminogenic thinking from baseline
Time Frame: changes from pre-treatment to post-treatment up to 12 weeks
changes from pre-treatment to post-treatment up to 12 weeks
Changes in self reported criminogenic thinking from baseline
Time Frame: changes from pre-treatment to 3 mos post-release up to 9 mos
changes from pre-treatment to 3 mos post-release up to 9 mos

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

George Mason University

Collaborators

National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: June P Tangney, Ph.D., George Mason University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2016

Primary Completion (Actual)

July 15, 2016

Study Completion (Actual)

July 15, 2016

Study Registration Dates

First Submitted

June 17, 2011

First Submitted That Met QC Criteria

June 23, 2011

First Posted (Estimate)

June 27, 2011

Study Record Updates

Last Update Posted (Actual)

April 25, 2017

Last Update Submitted That Met QC Criteria

April 21, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • R01DA014694-12 (U.S. NIH Grant/Contract)
  • R01DA014694 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Abuse

Clinical Trials on Impact of Crime Modules

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe